| 131 |
Breast Radiation Therapy (RT) Using Simultaneous Integrated Boost (SIB): Which Is the Optimal Intensity Modulated RT (IMRT) Technique? |
2014 |
| 132 |
Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era |
2014 |
| 133 |
Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era |
2014 |
| 134 |
Presentation and outcome of twenty patients with synchronous stage IV rectal carcinoma
|
2014 |
| 135 |
Risk-adapted Therapy of Pediatric Hodgkin Lymphoma
in Upper Egypt |
2014 |
| 136 |
Risk-adapted Therapy of Pediatric Hodgkin Lymphoma
in Upper Egypt |
2014 |
| 137 |
Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer |
2014 |
| 138 |
Simultaneous integrated boost for breast cancer radiotherapy: a planning study comparing different IMRT techniques |
2014 |
| 139 |
Trimodality bladder-sparing approach versus radical cystectomy for invasive bladder cancer
|
2014 |
| 140 |
Trimodality bladder-sparing approach versus radical cystectomy for invasive bladder cancer
|
2014 |